Regulation - Vaccines, Merck & Co

Filter

Current filters:

VaccinesMerck & Co

Popular Filters

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

17-03-2014

The president of pharma giant Merck & Co’s (NYSE: MRK) operations in Europe and Canada Bruno Strigini…

Anti-viralsCanadaDiabetesEuropeInterviewsMerck & CoMK-3475OncologyPharmaceuticalRegulationUKVaccines

Merck & Co expects to file BLA for HPV vaccine candidate V503 this year

Merck & Co expects to file BLA for HPV vaccine candidate V503 this year

25-10-2013

Merck & Co yesterday provided an overview of the clinical trial program for V503, the company’s investigational…

Merck & CoNorth AmericaPharmaceuticalRegulationResearchV503Vaccines

Sanofi Pasteur MSD first vaccine company in pilot for rapid European HTA

17-10-2013

Sanofi Pasteur MSD, a vaccines joint venture between drug major Sanofi of France’s Sanofi Pasteur…

Merck & CoPharmaceuticalRegulationSanofiSanofi Pasteur MSDVaccinesZostavax

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA

21-06-2013

The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe

22-04-2013

The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine

11-04-2013

Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Batch of mixed opinions from FDA advisory panels

21-06-2012

Advisory panels of the US Food and Drug Administration meeting yesterday came back with a mixture of…

carfilzomibKyprolisMerck & CoNorth AmericaOncologyOnyx PharmaceuticalsPfizerPharmaceuticalPneumovaxPrevnarRegulationSanofisemuloparinVaccines

Back to top